SEC Form 4 · accession 0001209191-15-086480
Kite Pharma, Inc. · KITE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arie Belldegrun
Officer — Chairman, President and CEO · Director · 10% Owner
Period of report
Dec 17, 2015
Accepted (ET)
Dec 21, 2015 · 8:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510580
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 17, 2015 | A | 28,200 | $0.00 | A | 28,200 | D | |
| Common StockF1 | holding | — | — | — | 2,138,324 | I | See Footnote | |
| Common StockF2 | holding | — | — | — | 2,275,472 | I | See Footnote | |
| Common StockF3 | holding | — | — | — | 159,329 | I | See Footnote | |
| Common StockF4 | holding | — | — | — | 430,190 | I | See Footnote | |
| Common StockF5 | holding | — | — | — | 500,000 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F6 | $63.87 | Dec 17, 2015 | A | 100,700 | A | — | Dec 16, 2025 | Common Stock | 100,700 | 100,700 | D |
Explanation of responses
- F1The securities are held in the name of Bioeast, LLC, of which the reporting person is a managing member. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F2The securities are held in the name of Arie and Rebecka Belldegrun as Trustees of the Belldegrun Family Trust dated February 18, 1994.
- F3The securities are held in the name of The Arie Belldegrun MD, Inc. Profit Sharing Plan, for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F4The securities are held in the name of MDRB Partnership, L.P., of which the reporting person is a managing partner. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F5The securities are held in the name of Bellco Capital, LLC, of which the reporting person is the Manager. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F625% of the shares subject to the stock option vest and become exercisable on the first anniversary of the grant date, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.